NABR Applauds CITES Committee's Decision on Cambodian Long-Tailed Macaque Trade

NABR Commends CITES Committee's Recent Decision

The National Association for Biomedical Research (NABR) has expressed its satisfaction with the recent resolution made by the CITES Standing Committee regarding the trade of Cambodian long-tailed macaques (Macaca fascicularis). In a pivotal meeting held in Geneva, Switzerland, the committee decided against imposing a suspension on the trade of these primates. This resolution highlights the international community's dedication towards a fair review process that prioritizes scientific data and counters misinformation propagated by extremist groups.

Japan was among the nations that formally requested the committee to defer any immediate action regarding the matter. The United States, Canada, and Kuwait, among other nations, echoed Japan's sentiments. During the discussions, no country supported the Secretariat's recommendation for a suspension based on erroneous beliefs surrounding Cambodian macaque exports. Many nations, including Japan and the U.S., emphasized the need for a thorough examination of new information provided by Cambodia before reaching a decision. This approach not only facilitates a comprehensive evaluation by the CITES Secretariat but also allows for the dispatch of an official delegation to Cambodia, ensuring that all processes remain transparent and evidence-based.

Furthermore, this prudent approach grants time for the U.S. House Committee on Natural Resources to finalize its review of the issue. Matthew R. Bailey, president of the NABR, remarked, “We are pleased that the committee recognizes that careful and fact-based deliberation is essential when making such significant decisions.” The availability of long-tailed macaques is crucial for advancing biomedical research specific to infectious diseases and cancer, which has extensive implications for public health.

Bailey emphasized the importance of this decision, stating that rejecting an unfounded trade suspension is a significant victory for scientific integrity and public health. The NABR is resolute in its commitment to advocate for science-based policies, ensuring that decisions regarding international wildlife trade support ethical biomedical research and medical advancements.

As an organization founded in 1979, the NABR aims to cultivate a healthy public policy regarding the humane use of animals in biomedical research, education, and testing. Their membership includes over 340 universities, medical and veterinary schools, hospitals, and pharmaceutical corporations that rely on responsible animal research to enhance human and animal health globally.

In light of the committee's decision, the NABR pledges to collaborate with stakeholders worldwide to defend transparency, scientific integrity, and responsible practices in animal research, fostering medical advancements that can save lives.

For further information about the NABR and its initiatives, visit www.nabr.org.

Contact: Eva Maciejewski, NABR (202) 967-8305 [email protected]